In an attempt to create a novel and more flexible EphA2-targeting system, we report here that proper peptide–biotin streptavidin complexes can be used to effectively target EphA2 in both breast- and pancreatic-cancer cells and tumors. The gene discussed is EPHA2; the disease is familial pancreatic carcinoma.